Dylan Maixner is Vice President of Consulting at Rancho BioSciences, where he helps life sciences organizations define, operationalize, and scale their R&D data strategies. He partners with clients on enterprise data foundations, governance, operating models, and future state process design, ensuring their strategies align with scientific, clinical, and business goals.

Before joining Rancho, Dylan was part of Accenture’s Global Life Sciences practice, advising biopharma companies on data and digital transformation programs. His scientific experience includes research at the National Institutes of Health in the Laboratory for Human Neurogenetics and industry work developing a personalized genetic pain panel.

Dylan holds a PhD in Pharmaceutical and Biomedical Sciences, an MBA from the University of Georgia, and a BS in Biology from the University of North Carolina at Chapel Hill.